These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9872988)

  • 1. Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D.
    Lenarcic B; Turk V
    J Biol Chem; 1999 Jan; 274(2):563-6. PubMed ID: 9872988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of thyroglobulin type-1 domains of equistatin.
    Galesa K; Pain R; Jongsma MA; Turk V; Lenarcic B
    FEBS Lett; 2003 Mar; 539(1-3):120-4. PubMed ID: 12650938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equistatin, a new inhibitor of cysteine proteinases from Actinia equina, is structurally related to thyroglobulin type-1 domain.
    Lenarcic B; Ritonja A; Strukelj B; Turk B; Turk V
    J Biol Chem; 1997 May; 272(21):13899-903. PubMed ID: 9153250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases.
    Lenarcic B; Krishnan G; Borukhovich R; Ruck B; Turk V; Moczydlowski E
    J Biol Chem; 2000 May; 275(20):15572-7. PubMed ID: 10748022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equistatin, a protease inhibitor from the sea anemone actinia equina, is composed of three structural and functional domains.
    Strukelj B; Lenarcic B; Gruden K; Pungercar J; Rogelj B; Turk V; Bosch D; Jongsma MA
    Biochem Biophys Res Commun; 2000 Mar; 269(3):732-6. PubMed ID: 10720485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
    Lalmanach G; Serveau C; Brillard-Bourdet M; Chagas JR; Mayer R; Juliano L; Gauthier F
    J Protein Chem; 1995 Nov; 14(8):645-53. PubMed ID: 8747425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual recombinant thyroglobulin type-1 domains are substrates for lysosomal cysteine proteinases.
    Pungercic G; Dolenc I; Dolinar M; Bevec T; Jenko S; Kolaric S; Turk V
    Biol Chem; 2002 Nov; 383(11):1809-12. PubMed ID: 12530546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and expression of functional equistatin.
    Galesa K; Strukelj B; Bavec S; Turk V; Lenarcic B
    Biol Chem; 2000 Jan; 381(1):85-8. PubMed ID: 10722055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin.
    Nicklin MJ; Barrett AJ
    Biochem J; 1984 Oct; 223(1):245-53. PubMed ID: 6388564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
    Turk B; Turk V; Turk D
    Biol Chem; 1997; 378(3-4):141-50. PubMed ID: 9165064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
    Estrada S; Pavlova A; Björk I
    Biochemistry; 1999 Jun; 38(22):7339-45. PubMed ID: 10353845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin S and cruzipain are inhibited by equistatin from Actinia equina.
    Stoka V; Lenarcic B; Cazzulo JJ; Turk V
    Biol Chem; 1999 May; 380(5):589-92. PubMed ID: 10384966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
    Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterisation of chicken L- and H-kininogens and their interaction with chicken cysteine proteinases and papain.
    Kos J; Dolinar M; Turk V
    Agents Actions Suppl; 1992; 38 ( Pt 1)():331-9. PubMed ID: 1466284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and -161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Kinetic studies up to pH 8 of the hydrolysis of N-alpha-benzyloxycarbonyl-L-arginyl-L-arginine 2-naphthylamide catalysed by cathepsin B and of L-arginine 2-naphthylamide catalysed by cathepsin H.
    Willenbrock F; Brocklehurst K
    Biochem J; 1985 Apr; 227(2):521-8. PubMed ID: 3890831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of cathepsin S by its propeptide--specificity and mechanism of action.
    Maubach G; Schilling K; Rommerskirch W; Wenz I; Schultz JE; Weber E; Wiederanders B
    Eur J Biochem; 1997 Dec; 250(3):745-50. PubMed ID: 9461297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aspartic proteinases by alpha 2-macroglobulin.
    Thomas DJ; Richards AD; Kay J
    Biochem J; 1989 May; 259(3):905-7. PubMed ID: 2471514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
    Xing R; Hanzlik RP
    J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site.
    Alvarez-Fernandez M; Barrett AJ; Gerhartz B; Dando PM; Ni J; Abrahamson M
    J Biol Chem; 1999 Jul; 274(27):19195-203. PubMed ID: 10383426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.
    Portaro FC; Santos AB; Cezari MH; Juliano MA; Juliano L; Carmona E
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):123-9. PubMed ID: 10727410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.